Lien TA, Dhakal S, Fosdahl Wium AM, Bergholtz H, Gunesten S, Flatekvål HM, Nebdal D, Vu P, Hurtado A, Norum JH, Sorlie T (2026)
FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancer
Cancer Res Commun (in press)
DOI 10.1158/2767-9764.CRC-25-0821, PubMed 42617046

Norum JH, Schandiz H, Sauer T, Geisler J, Farkas L, Hekmati N, Strell C, Bergholtz H, Sørlie T (2026)
Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ
Sci Rep (in press)
DOI 10.1038/s41598-026-60008-9, PubMed 42386958

Chmelova L, Davies HR, Degasperi A, Rinaldi G, Wils L, Black D, Memari Y, Koh GCC, Shooter S, Mulder L, Kristel P, Szuhai K, Prasad G, Wong IT, Luebeck J, Kumar Y, Czarnecki J, Basyuni S, Kingsbury Z, Ross MT, Garred Ø, Riis M, Lande KT, Vallon-Christersson J, Ehinger A, Agrawal A, McIntosh SA, Bafna V, Mischel PS, Grand Challenges PRECISION Consortium et al. (2026)
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-72952-1, PubMed 42156386